Literature DB >> 1772634

Structure of oligomeric beta B2-crystallin: an application of the T2 translation function to an asymmetric unit containing two dimers.

H P Driessen1, B Bax, C Slingsby, P F Lindley, D Mahadevan, D S Moss, I J Tickle.   

Abstract

The molecular structure of the main subunit of the beta-crystallins, components of the vertebrate eye lens, has recently been solved by molecular replacement at 2.1 A resolution [Bax, Lapatto, Nalini, Driessen, Lindley, Mahadevan, Blundell & Slingsby (1990). Nature (London), 347, 776-780]. The protein, beta B2, is a dimer in solution, but a tetramer in the crystal with one subunit in the asymmetric unit of space group I222. Using the crystallographic dimer from this I-centred form the structure of a C222 crystal form of the beta B2 protein with four subunits in the asymmetric unit has now been solved by molecular replacement at 3.3 A. The solution involved the use of a new translation function for non-crystallographic symmetry, based on the T2 function of Crowther & Blow [Acta Cryst. (1967), 23, 544-548].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772634     DOI: 10.1107/s0108768191009163

Source DB:  PubMed          Journal:  Acta Crystallogr B        ISSN: 0108-7681


  3 in total

1.  Circular permutation of betaB2-crystallin changes the hierarchy of domain assembly.

Authors:  G Wright; A K Basak; K Wieligmann; E M Mayr; C Slingsby
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

2.  Intermolecular protein interactions in solutions of bovine lens beta L-crystallin. Results from 1/T1 nuclear magnetic relaxation dispersion profiles.

Authors:  S H Koenig; R D Brown; A K Kenworthy; A D Magid; R Ugolini
Journal:  Biophys J       Date:  1993-04       Impact factor: 4.033

3.  Structural analyses of a constitutively active mutant of exchange protein directly activated by cAMP.

Authors:  Mark A White; Sheng Li; Tamara Tsalkova; Fang C Mei; Tong Liu; Virgil L Woods; Xiaodong Cheng
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.